Pura Vida Investments’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-55,596
Closed -$1.4M 205
2022
Q3
$1.4M Buy
+55,596
New +$1.4M 0.08% 75